MedPath

Si-Bone

Si-Bone logo
🇺🇸United States
Ownership
Public
Established
2008-04-01
Employees
344
Market Cap
-
Website
http://www.si-bone.com
Introduction

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

SI-BONE's iFuse TORQ TNT Implant System Receives FDA Clearance for Pelvic Fragility Fractures

• SI-BONE's iFuse TORQ TNT implant system has received FDA 510(k) clearance, offering a novel solution for pelvic fragility fractures. • The TNT system is designed to address the specific anatomical and bone mineral density needs of the sacrum and ilium, potentially improving treatment outcomes. • TNT's design aims to enhance early fixation and reduce screw backout, facilitating earlier patient weight-bearing and mobilization post-surgery. • The sacroiliac joint fusion market is projected to grow significantly, with SI-BONE's advancement positioning it well to address unmet clinical needs.
© Copyright 2025. All Rights Reserved by MedPath